Singapore Medical Group Limited

Catalist:5OT Stock Report

Market Cap: S$192.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Singapore Medical Group Past Earnings Performance

Past criteria checks 4/6

Key information

9.4%

Earnings growth rate

6.3%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate9.3%
Return on equity8.7%
Net Margin14.0%
Last Earnings Update30 Jun 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Singapore Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

Catalist:5OT Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2210515300
31 Mar 2210315290
31 Dec 2110116280
30 Sep 219914270
30 Jun 219812270
31 Mar 219311250
31 Dec 20879240
30 Sep 208910250
30 Jun 208910250
31 Mar 209312260
31 Dec 199514260
30 Sep 199113250
30 Jun 198913240
31 Mar 198713240
31 Dec 188513230
30 Sep 188212220
30 Jun 187811210
31 Mar 187310190
31 Dec 17688190
30 Sep 17607170
30 Jun 17536150
31 Mar 17464140
31 Dec 16422120
30 Sep 16392110
30 Jun 16361100
31 Mar 16330100

Quality Earnings: 5OT has high quality earnings.

Growing Profit Margin: 5OT's current net profit margins (14%) are higher than last year (12.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 5OT's earnings have grown by 9.4% per year over the past 5 years.

Accelerating Growth: 5OT's earnings growth over the past year (17.8%) exceeds its 5-year average (9.4% per year).

Earnings vs Industry: 5OT earnings growth over the past year (17.8%) underperformed the Healthcare industry 17.8%.


Return on Equity

High ROE: 5OT's Return on Equity (8.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.